Articles From: PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout to Protiviti and ISACA Study Reveals Disparity Between Growth of IT in Business and Auditing of IT Risks


2014/12/12
WILMINGTON, Del.
Sign-up for PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/11/10
Leiden, The Netherlands, Nov.
Sign-up for Prosensa Holding N.V. to Webcast Conference Call Discussing 3rd Quarter 2014 Financial Results and Corporate Update on November 17, 2014 investment picks
2014/11/24
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Prosensa Holding N.V. (“Prosensa”) (NasdaqGS: RNA) concerning the acquisition by BioMarin Pharmaceuticals.
Sign-up for PROSENSA SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by BioMarin May be Unfair to Shareholders investment picks
2014/11/7
Leiden, The Netherlands, Nov.
Sign-up for Prosensa to Present at Upcoming Investor Conferences investment picks
2014/12/8
Leiden, The Netherlands, Dec.
Sign-up for Prosensa Wins Scrip 'Biotech Company of the Year' 2014 Award investment picks
Prosensa Holding's U.S-listed shares (RNA) soared 63% in premarket trade Monday, after Dutch biotechnology company agreed to be acquired by BioMarin Pharmaceutical (BMRN) in a deal valued at $680 million.
Sign-up for Prosensa's stock soars after buyout deal with BioMarin investment picks
2015/1/6
ProShares, a premier provider of alternative ETFs, announced today that it has taken several major steps to enhance its distribution capabilities.
Sign-up for ProShares Makes Major Investments in Distribution Capabilities investment picks
2014/12/18
ProShares, a premier provider of alternative ETFs, announced today that it expects that none of its 128 equity and fixed income ETFs will pay any 2014 capital gain distributions.
Sign-up for ProShares Trust Expects Zero Capital Gain Distributions for Its ETFs investment picks
Deal Supports Diversification Strategy of the Group via Level 3 Global Solutions BROOMFIELD, Colo.
Sign-up for ProSiebenSat.1 Media AG Selects Level 3 to Enhance Security and Content Delivery Performance investment picks
http://media.marketwire.com/attachments/201309/189968_PSEC.png http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164850&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Corporation Webcast Thursday, December 18, 2014 at 3:00 p.m. ET investment picks
http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157045&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Earns $0.44 of Taxable Income per Share for September Quarter and Announces Intention to Unlock Value by Spinning off "Pure Play" Business Strategies to Shareholders investment picks
http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155409&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Invests $55.4 Million in 16 Apartment and Self-Storage Real Estate Properties, Bringing Its Total Real Estate Portfolio to 48 Properties investment picks
http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153873&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call investment picks
2014/10/29
- Third quarter 2014 earnings per share (diluted) increased 20.9% to $1.10 compared with the third quarter 2013 - Net income increased $21.292 million or 38.5% compared with the third quarter 2013 - Nonperforming assets remain low at 0.27% of third quarter average earning assets - Loans increased $3.186 billion or 51.5% compared with the third quarter 2013 - Deposits increased $4.558 billion or 36.6% compared with the third quarter 2013 - Dividend increased 13.5% to $0.2725 for the fourth quarter 2014 HOUSTON , Oct.
Sign-up for Prosperity Bancshares, Inc.® Reports Record Third Quarter 2014 Earnings investment picks
2014/10/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153641&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Protect Your Home (and Wallet) From Ol' Man Winter investment picks
2009/10/01
Eleven ways to stay informed and make the best choices.
Sign-up for Protecting Your Interests During Divorce investment picks
2014/11/3
The Board of Directors of Protective Life Corporation (NYSE:PL) declared a quarterly dividend of $0.24 per share.
Sign-up for Protective Declares Quarterly Dividend investment picks
2014/11/3
Protective Life Corporation (NYSE: PL) (“the Company”) today reported results for the third quarter of 2014.
Sign-up for Protective Reports Third Quarter 2014 Financial Results investment picks
2014/12/15
Protective Life Corporation (NYSE: PL) (“Protective”) today announced that the transaction contemplated by the Agreement and Plan of Merger dated June 3, 2014, with Dai-ichi Life Insurance Company Limited (Dai-ichi), a kabushiki kaisha organized under the laws of Japan, and DL Investment (Delaware), Inc., a Delaware corporation and wholly owned subsidiary of Dai-ichi, continues to progress toward closing of the Merger in the ordinary course.
Sign-up for Protective Update Regarding Dai-ichi Transaction investment picks
2015/1/14
Latest #ThisIsWholesome snack serves up great tasting fuel for active kids (and adults!) EAST HANOVER, N.J. , Jan.
Sign-up for Protein and Whole Grains are a GO with Honey Maid's All New Go Bites investment picks
WALTHAM, Mass., Nov.
Sign-up for Proteon Therapeutics Announces Third Quarter 2014 Financial Results investment picks
2014/12/2
New and Updated Results Show 50% Response Rate in 14 Cardiac-Evaluable Patients New Data Show 43% Best Response Rate in 14 Renal-Evaluable Patients Cardiac and Renal Biomarker Responses of Single-Agent NEOD001-Treated Patients Compare Favorably with Historical Data in Patients with AL Amyloidosis NEOD001 Continues to be Safe and Well-Tolerated, with No Dose Limiting Toxicities Observed Excellent Pharmacokinetic Properties and No Immunogenicity Currently Enrolling Expansion Portion of Phase 1/2 Trial with New Data Expected to be Presented Annually at Appropriate Medical Conferences, Beginning in 2015 Prothena to Host Investor Conference Call and Webcast Today at 4:30 p.m. ET DUBLIN, Ireland, Dec.
Sign-up for Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis investment picks
First Investigational Immunotherapy for AL Amyloidosis to Receive FDA Fast Track Designation Follows Recent Initiation of The VITAL Amyloidosis Study, a Global Phase 3 Registrational Trial of NEOD001 for Patients with AL Amyloidosis DUBLIN, Ireland, Dec.
Sign-up for Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients With AL Amyloidosis investment picks
Net cash used in operating activities was $12.3 million in the third quarter, while quarter-end cash position of $306.2 million provides solid runway for advancement of multiple programs  Initial indication for PRX003 targeted to psoriasis to leverage rapid proof-of-biology and inform future clinical pathway  NEOD001, for the treatment of AL amyloidosis, remains on track for Phase 2/3 study initiation later this year DUBLIN, Ireland, Nov.
Sign-up for Prothena Reports Third Quarter 2014 Financial Results and R&D Progress investment picks
2014/11/19
Survey highlights the evolving role of IT audit professionals MENLO PARK, Calif.
Sign-up for Protiviti and ISACA Study Reveals Disparity Between Growth of IT in Business and Auditing of IT Risks investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout to Protiviti and ISACA Study Reveals Disparity Between Growth of IT in Business and Auditing of IT Risks
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent